WallStreetZenWallStreetZen

NASDAQ: TARS
Tarsus Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Tarsus Pharmaceuticals earnings were -$48.3M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest TARS earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$7.0M, down 16.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TARS reported annual earnings of -$66.4M, with -42.5% growth.

TARS earnings history

Current Revenue
$535.1M
Current Earnings
-$48.3M
Current Profit Margin
-9%

TARS Return on Equity

Current Company
-14.2%
Current Industry
-141.9%
Current Market
13.5%
TARS's Return on Equity (-14.2%)... subscribe to Premium to read more.
High Return on Equity Performance

TARS Return on Assets

Current Company
-8.9%
Current Industry
-13.7%
TARS is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TARS announces earnings.

TARS Return on Capital Employed

Current Company
-8%
Current Industry
-9.5%
TARS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TARS vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TARS-$32.62M-$48.27MN/A-$1.13
IRON-$236.92M-$241.60MN/A-$6.62
RARE-$571.22M-$608.92MN/A-$6.10
IDYA-$135.46M-$140.06MN/A-$1.58
ELVN-$98.21M-$98.78MN/A-$1.67
View Top Biotech Stocks

Tarsus Pharmaceuticals Earnings Reports & History FAQ

What were Tarsus Pharmaceuticals's earnings last quarter?

On TARS's earnings call on Invalid Date, Tarsus Pharmaceuticals (NASDAQ: TARS) reported Q1 2026 earnings per share (EPS) of -$0.16, up 75% year over year. Total TARS earnings for the quarter were -$6.97 million. In the same quarter last year, Tarsus Pharmaceuticals's earnings per share (EPS) was -$0.64.

If you're new to stock investing, here's how to buy Tarsus Pharmaceuticals stock.

Is Tarsus Pharmaceuticals profitable or losing money?

As of the last Tarsus Pharmaceuticals earnings report, Tarsus Pharmaceuticals is currently losing money. Tarsus Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$48.27 million, a 54.01% decrease year over year.

What was TARS's earnings growth in the past year?

As of Tarsus Pharmaceuticals's earnings date in Invalid Date, Tarsus Pharmaceuticals's earnings has grown year over year. TARS earnings in the past year totalled -$48.27 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.